MedTrace Logo

Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls

NCT03679858 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-09-24

No results posted yet for this study

Summary

To search for simple laboratory methods selecting patients with low/non-responsiveness to P2Y12 receptor antagonists.

Conditions

  • Cerebrovascular Disorders
  • Platelet Refractoriness
  • Platelet Aggregation, Spontaneous

Interventions

OTHER

Platelet function test

Ex vivo platelet aggregation analysis by Multiplate aggregometer

Sponsors & Collaborators

  • University of Pecs

    lead OTHER

Principal Investigators

  • Tihamer Molnar, MD, PhD · University of Pécs Medical School

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-10-01
Completion
2019-01-01

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03679858 on ClinicalTrials.gov